Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia

The Risk of Hyponatremia with Desmopressin Use for Nocturnal Polyuria

(2015) Eun Young Choi et al.   AMERICAN JOURNAL OF NEPHROLOGY

Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations

(2013) Joseph G. Verbalis et al.   AMERICAN JOURNAL OF MEDICINE

Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Women with Nocturia: Results of a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study

(2013) Peter K. Sand et al.   JOURNAL OF UROLOGY

Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Men with Nocturia: Results of a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study

(2013) Jeffrey P. Weiss et al.   JOURNAL OF UROLOGY

Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double-blind, placebo-controlled trial

(2012) Jeffrey P. Weiss et al.   NEUROUROLOGY AND URODYNAMICS

Hyponatremia and bone: an emerging relationship

(2011) Ewout J. Hoorn et al.   Nature Reviews Endocrinology

Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study

(2008) H. Lottmann et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE